Moreover, the meta-analysis has the further advantage of providing an outlook and an estimate of PIK3CA exon-selectivity and standardized rate of mutation in different cancer types, although this might be affected by the limitations derived from retrospective studies. Here, PIK3CA is linked to cancer.